Transmission of antiviral drug resistant hepatitis B virus: Implications for public health and patient management

Journal of Gastroenterology and Hepatology (Australia)

Volumn 25, Issue 4, 2010, Pages 649-651

  Locarnini, Stephen ^a  

^a VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR; ENTECAVIR; LAMIVUDINE; TELBIVUDINE; TENOFOVIR;

ANTIVIRAL RESISTANCE; ANTIVIRAL THERAPY; EDITORIAL; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER FUNCTION TEST; PATIENT CARE; PRIORITY JOURNAL; TREATMENT RESPONSE; VIRUS GENE; VIRUS MUTATION; VIRUS REPLICATION; VIRUS TRANSMISSION;

EID: 77950118836     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2010.06255.x     Document Type: Editorial

References (18)

1. Zoulim F, Locarnini S. Hepatitis B virus resistance to nucleos(t)ide analogues. Gastroenterology 2009 137 : 1593 1608 e1-2.
2. Delaney WEt, Yang H, Westland CE et al. The hepatitis B virus polymerase mutation rtV173L is selected during lamivudine therapy and enhances viral replication in vitro. J. Virol. 2003 77 : 11833 11841.
3. Ogata N, Fujii K, Takigawa S, Nomoto M, Ichida T, Asakura H. Novel patterns of amino acid mutations in the hepatitis B virus polymerase in association with resistance to lamivudine therapy in japanese patients with chronic hepatitis B. J. Med. Virol. 1999 59 : 270 276.
4. Locarnini SA. Hepatitis B virus surface antigen and polymerase gene variants: potential virological and clinical significance. Hepatology 1998 27 : 294 297.
5. Waters JA, Kennedy M, Voet P et al. Loss of the common 'A' determinant of hepatitis B surface antigen by a vaccine-induced escape mutant. J. Clin. Invest. 1992 90 : 2543 2547.
6. Carman WF, Zanetti AR, Karayiannis P et al. Vaccine-induced escape mutant of hepatitis B virus. Lancet 1990 336 : 325 329.
7. Torresi J. The virological and clinical significance of mutations in the overlapping envelope and polymerase genes of hepatitis B virus. J. Clin. Virol. 2002 25 : 97 106.
8. Kamili S, Sozzi V, Thompson G et al. Efficacy of hepatitis B vaccine against antiviral drug-resistant hepatitis B virus mutants in the chimpanzee model. Hepatology 2009 49 : 1483 1491.
9. Thibault V, Aubron-Olivier C, Agut H, Katlama C. Primary infection with a lamivudine-resistant hepatitis B virus. AIDS 2002 16 : 131 133.
10. Besisik F, Karaca C, Akyuz F et al. Occult HBV infection and YMDD variants in hemodialysis patients with chronic HCV infection. J. Hepatol. 2003 38 : 506 510.
11. Kobayashi S, Ide T, Sata M. Detection of YMDD motif mutations in some lamivudine-untreated asymptomatic hepatitis B virus carriers. J. Hepatol. 2001 34 : 584 586.
12. Hayashi K, Katano Y, Ishigami M, et al. Prevalence and clinical characterization of patients with acute hepatitis B induced by lamivudine-resistant strains. J. Gastroenterol. Hepatol. 2010 25 : 745 749.
13. Clements C, Coghlan B, Creati M, Locarnini S, Tedder RS, Torresi J. Global control of hepatitis B infection: does the potential for antigenic change of the virus in the face of antiviral treatment affect the global hepatitis B immunization programme? Bull. WHO 2009 (in press).
14. Leigh Brown AJ, Frost SD, Mathews WC et al. Transmission fitness of drug-resistant human immunodeficiency virus and the prevalence of resistance in the antiretroviral-treated population. J. Infect. Dis. 2003 187 : 683 686.
15. Little SJ, Holte S, Routy JP et al. Antiretroviral-drug resistance among patients recently infected with HIV. N. Engl. J. Med. 2002 347 : 385 394.
16. Hirsch MS, Brun-Vezinet F, Clotet B et al. Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel. Clin. Infect. Dis. 2003 37 : 113 128.
17. Little SJ, Frost SD, Wong JK et al. Persistence of transmitted drug resistance among subjects with primary human immunodeficiency virus infection. J. Virol. 2008 82 : 5510 5518.
18. EASL Clinical Practice Guidelines: management of chronic hepatitis B. Hepatology 2009 50 : 227 242.